CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 101 enrolled
Drug / intervention
Levothyroxine Sodiumdrug
Likely dose
Levothyroxine sodium (dose not specified)AI-extracted
Key inclusion· 2
  • ✓Clinical diagnosis of thyroid disease requiring radioiodine treatment
  • ✓Clinical diagnosis of thyroid disease requiring follow-up but no ablative treatment (control group)
Key exclusion· 6
  • ✕Pediatric patients (age requirement not explicitly stated but pediatric patients excluded)
  • ✕Interfering comorbidity
  • ✕Non-thyroidal illness
  • ✕Pregnancy

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03880578
NCT03880578N/ACompleted
CompareCT.gov

Influence of Radioiodine Treatment on Thyroid Function and Quality of Life of Patients

Klinikum Lüdenscheid·observational·Posted Mar 19, 2019·Updated Oct 29, 2024

In Brief

An observational study evaluating Levothyroxine Sodium for Thyroid; Deficiency and Quality of Life. Completed, enrolled 101 participants across 1 site.

Detailed Summary

In this study, patients are prospectively followed after radioiodine treatment to assess the relationship between thyroid status and their quality of life after thyroid ablative treatment. A third treatment arm after surgery has been stopped, as deemed currently not feasible to achieve its target.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsThyroid; Deficiency, Quality of Life
CountriesGermany
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedMar 19, 2019
Enrollment StartApr 1, 2019
Primary CompletionMar 15, 2022
TodayJul 2, 2026
Enrollment to primary: 3.0 yearsPosted 7.3 years ago

Interventions

Levothyroxine Sodiumdrug

thyroid hormone replacement